Avience Biomedicals Ltd Quarterly Result

Avience Biomedicals Ltd Quarterly Result

Image

Avience Biomedicals Ltd

NSE: Avience

Net Profit - Last Quarter

₹ - Cr.

Last updated on: Jul 29, 2026

null Quarterly Results Key Highlights

No data available

null Quarterly Results Analysis

Market Price of Avience Biomedicals Ltd

1M

1Y

3Y

5Y

Monitoring Avience Biomedicals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Jul 2026259.65
27 Jul 2026259.5
24 Jul 2026259.75
23 Jul 2026251.2
22 Jul 2026245.5
21 Jul 2026251.5
20 Jul 2026261.85
17 Jul 2026222.85
16 Jul 2026277.5
15 Jul 2026273.75

Historical Revenue of Avience Biomedicals Ltd

No data available

* All values are in crore

Historical EBITDA of Avience Biomedicals Ltd

No data available

* All values are in crore

Historical Net Profit of Avience Biomedicals Ltd

No data available

* All values are in crore

Avience Biomedicals Ltd News Hub

Avience Biomedicals schedules board meeting

Avience Biomedicals will hold a meeting of the Board of Directors of the Company on 13 July 2026.

Read more

14 Jul 26

NSE SME Avience Biomedicals debuts with a powerful heartbeat

The scrip was listed at Rs 395.20, a 90% premium to the initial public offer (IPO) price. The stock

Read more

25 Jun 26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Avience Biomedicals Ltd

  • Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
  • Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of Incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
  • In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

FAQs for Quarterly Results of null

What key financial metrics are included in Avience Biomedicals Ltd's quarterly results?

Key financial metrics in Avience Biomedicals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Avience Biomedicals Ltd announce its quarterly results?

Avience Biomedicals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Avience Biomedicals Ltd's quarterly performance impact its stock price?

Avience Biomedicals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Avience Biomedicals Ltd's quarterly results on dividends?

The impact of Avience Biomedicals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Avience Biomedicals Ltd's quarterly results?

Yes, Avience Biomedicals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions